{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:19:07Z","timestamp":1761128347218},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.semarthrit.2005.03.006","type":"journal-article","created":{"date-parts":[[2005,8,9]],"date-time":"2005-08-09T11:30:18Z","timestamp":1123587018000},"page":"1-4","source":"Crossref","is-referenced-by-count":14,"title":["Recommendations for the Registration of Agents to be Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Updated Recommendations from the Group for the Respect of Ethics and Excellence in Science"],"prefix":"10.1016","volume":"35","author":[{"given":"Eric C.","family":"Abadie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Devogealer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann D.","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique J.","family":"Ethgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles M.","family":"Bouvenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gottfried","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Laslop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Orloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe M.","family":"Vanderauwera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre D.","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willard H.","family":"Dere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy D.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard P.","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Menkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Vanhaelst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.","family":"Mitlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannis","family":"Tsouderos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves L.","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2005.03.006_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"Van Staa","year":"2000","journal-title":"Q J Med"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/eje.0.1370209","article-title":"Glucocorticoid osteoporosis\u2014mechanism and management","volume":"137","author":"Reid","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000441-199701000-00007","article-title":"Corticosteroid-induced osteoporosis","volume":"313","author":"Adachi","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1359\/jbmr.1999.14.7.1061","article-title":"New developments in the pathogenesis and treatment of steroid-induced osteoporosis","volume":"14","author":"Manolagas","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00060793-200012000-00005","article-title":"Glucocorticoid-induced osteoporosis","volume":"7","author":"Canalis","year":"2000","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis\u2014a randomized, controlled-study","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib8","first-page":"99","article-title":"Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis","volume":"5","author":"Rizzato","year":"1988","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thx.46.11.803","article-title":"Vertebral fractures in steroid dependent asthma and involutional osteoporosis\u2014a comparative study","volume":"46","author":"Luengo","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1359\/jbmr.2000.15.5.952","article-title":"Corticosteroids do not alter the threshold for vertebral fracture","volume":"15","author":"Selby","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"Van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s002239900134","article-title":"Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"59","author":"Compston","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib13","article-title":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"44","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib14","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1001\/archinte.163.21.2619","article-title":"Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the department of veterans affairs","volume":"163","author":"Adler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1385\/JCD:1:4:317","article-title":"Immunosuppressant drugs and bone disease: a clinician's perspective","volume":"1","author":"Epstein","year":"1998","journal-title":"J Clin Densitom"},{"doi-asserted-by":"crossref","unstructured":"Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med 1998;459-69.","key":"10.1016\/j.semarthrit.2005.03.006_bib16","DOI":"10.1016\/S0002-9343(98)00081-3"},{"unstructured":"Committee for Proprietary Medicinal Products (CPMP), Efficacy Working Party Note for Guidance on Involutional Osteoporosis in Women CPMP\/EWP\/552\/95, 1999.","key":"10.1016\/j.semarthrit.2005.03.006_bib17"},{"unstructured":"Food and Drug Administration (FDA). Preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Washington, DC, April 1994.","key":"10.1016\/j.semarthrit.2005.03.006_bib18"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S8756-3282(98)00084-2","article-title":"Osteoprogenitor cells in cell population derived from mouse and rat calvaria differ in their response to corticosterone, cortisol, and cortisone","volume":"23","author":"Bellows","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00297297","article-title":"Biphasic dose-response curves of cortisol effects on rat diaphyseal bone biomechanics","volume":"50","author":"Ferretti","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(96)00170-6","article-title":"Skeletal response to corticosteroid deficiency and excess in growing male rats","volume":"19","author":"Li","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib22","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"Van Staa","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the treatment and prevention of glucorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib26","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss: a twelve month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2005.03.006_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s198-002-8331-3","article-title":"The use of placebo-controlled and non inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis","volume":"13","author":"Delmas","year":"2002","journal-title":"Osteoporos Int"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017205000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017205000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T22:00:24Z","timestamp":1548280824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017205000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0049017205000521"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2005.03.006","relation":{},"ISSN":["0049-0172"],"issn-type":[{"type":"print","value":"0049-0172"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}